Effect of the CSF1R inhibitor PLX3397 on remyelination of corpus callosum in a cuprizone‐induced demyelination mouse model
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis (MS) is a chronic inflammatory disease affecting the central nervous system (CNS). Despite introducing multiple immunomodulatory approaches for MS, there are still major concerns about possible ways for improving remyelination in this disease. Microglia exert essential roles in regulation of myelination processes, and interaction between colony‐stimulating factor 1 (CSF1) with its receptor CSF1R is considered as a key regulator of microglial differentiation and survival. The aim of this study was to investigate possible roles for a CSF1R inhibitor PLX3397 in recovery of central myelination processes. Chronic demyelination was induced in mice by addition of 0.2% cuprizone to the chow for 12 weeks. Next, animals were undergoing a diet containing 290 mg/kg PLX3397 to induce microglial ablation. The PLX3397 treatment caused a significant decrease in the rate of expression for the CSF1/CSF1R axis, and a reduction in the protein expressions for the microglial marker Iba‐1 and for the oligodendrocyte marker Olig‐2. Findings from Luxol fast blue (LFB) staining and transmission electron microscopy (TEM) showed an increase in the rate of myelination for the mice receiving PLX3397. The rate of destruction in the nerve fibers and the extent of the gaps formed between layers of myelin sheaths was also reduced after the treatment with PLX3397. In addition, animals experienced an improvement in recovery of motor deficit after receiving PLX3397 (for all P < 0.05). It could be concluded that PLX3397 could retain myelination in the MS model possibly through regulation of the myelin environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Elmore, M. R. P., Najafi, A. R., Koike, M. A., Dagher, N. N., Spangenberg, E. E., Rice, R. A., Kitazawa, M., Matusow, B., Nguyen, H., West, B. L., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.040 · Cited by 1,968 · cited 4×
“After receiving the final dose of cuprizone, animals were undergoing the treatment with the microglial depletion drug PLX3397 (Active Biochem, Hong Kong).(18) PLX3397 at dosage 290mg/kg was administered for 21 consecutive days.”
BackgroundMethodResultInfluentialMicroglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis
Sierra, A., Encinas, J. M., Deudero, J. J. P., Chancey, J. H., Enikolopov, G., Overstreet-Wadiche, L. S., Tsirka, S. E., & Maletic-Savatic, M. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.08.014 · Cited by 1,622 · cited 6×
“After infection or injury to the CNS, microglia play critical roles for clearance of debris and restoring a steady state within the CNS.(6,7) Despite these beneficial effects for the innate immune cells, there is compelling evidence for having detrimental roles in various CNS diseases.”
BackgroundInfluentialDepletion of microglia and inhibition of exosome synthesis halt tau propagation
Asai, H., Ikezu, S., Tsunoda, S., Medalla, M., Luebke, J., Haydar, T., Wolozin, B., Butovsky, O., Kügler, S., & Ikezu, T. (2015) · Nature Neuroscience · doi:10.1038/nn.4132 · Cited by 1,591 · cited 1×
“For other diseases such as Alzheimer it is documented that PLX3397‐induced microglia depletion could cause a noticeable amelioration in tauopathy parallel to the neurotoxicity.(46) Microglia release cytokines like TNF and MIP‐1β to attract leukocytes within the circulation to the injured site, so a surge of an inflamm…”
BackgroundDai, X.-M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., & Stanley, E. R. (2002) · Blood · doi:10.1182/blood.v99.1.111 · Cited by 1,184
Wang, Y., Szretter, K. J., Vermi, W., Gilfillan, S., Rossini, C., Cella, M., Barrow, A. D., Diamond, M. S., & Colonna, M. (2012) · Nature Immunology · doi:10.1038/ni.2360 · Cited by 1,011 · cited 7×
“For other diseases such as Alzheimer it is documented that PLX3397‐induced microglia depletion could cause a noticeable amelioration in tauopathy parallel to the neurotoxicity.46 Microglia release cytokines like TNF and MIP‐1β to attract leukocytes within the circulation to the injured site, so a surge of an inflammat…”
BackgroundResultInfluentialSelective Ablation of Proliferating Microglial Cells Exacerbates Ischemic Injury in the Brain
Lalancette-Hébert, M., Gowing, G., Simard, A., Weng, Y. C., & Kriz, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5360-06.2007 · Cited by 874
CSF-1 receptor signaling in myeloid cells.
Stanley, E. R., & Chitu, V. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021857 · Cited by 825
Experimental autoimmune encephalomyelitis repressed by microglial paralysis
Heppner, F. L., Greter, M., Marino, D., Falsig, J., Raivich, G., Hövelmeyer, N., Waisman, A., Rülicke, T., Prinz, M., Priller, J., et al. (2005) · Nature Medicine · doi:10.1038/nm1177 · Cited by 732 · cited 7×
“For other diseases such as Alzheimer it is documented that PLX3397‐induced microglia depletion could cause a noticeable amelioration in tauopathy parallel to the neurotoxicity.46 Microglia release cytokines like TNF and MIP‐1β to attract leukocytes within the circulation to the injured site, so a surge of an inflammat…”
BackgroundInfluentialSpangenberg, E. E., Lee, R. J., Najafi, A. R., Rice, R. A., Elmore, M. R. P., Blurton-Jones, M., West, B. L., & Green, K. N. (2016) · Brain · doi:10.1093/brain/aww016 · Cited by 695
Erblich, B., Zhu, L., Etgen, A. M., Dobrenis, K., & Pollard, J. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026317 · Cited by 649 · cited 3×
“It has been attested that microglia are the only cell type in the brain that express colony‐stimulating factor 1 receptor (CSF1R) under normal conditions, and that expression of this receptor is necessary for normal function of the cells.(12,13) There are two natural ligands for this receptor: CSF1 and interleukin‐34…”
Background
Cited by
Microglia in multiple sclerosis: protectors turn destroyers
Yong, V. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.023 · Cited by 185
Microglia promote remyelination independent of their role in clearing myelin debris
Baaklini, C. S., Ho, M. F. S., Lange, T., Hammond, B. P., Panda, S. P., Zirngibl, M., Zia, S., Himmelsbach, K., Rana, H., Phillips, B., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113574 · Cited by 84
Dynamic Responses of Microglia in Animal Models of Multiple Sclerosis
Plastini, M. J., Desu, H. L., & Brambilla, R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00269 · Cited by 48
Wylot, B., Mieczkowski, J., Niedziolka, S., Kaminska, B., & Zawadzka, M. (2019) · Cells · doi:10.3390/cells9010099 · Cited by 29
Tarale, P., & Alam, M. M. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-00958-4 · Cited by 26
Tahmasebi, F., Pasbakhsh, P., Barati, S., Madadi, S., & Kashani, I. R. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30090 · Cited by 25
“Then, microglia were depleted by CSF1R inhibitor (PLX3397) according to our previous study (Tahmasebi et al., 2019).”
MethodSelf-citationMultifaceted response of microglia in the cuprizone model of demyelination
Shanahan, A., Eichfeld, G., Todd, L., & Niraula, A. (2026) · PLOS One · doi:10.1371/journal.pone.0355981
Metadata
- Authors
- Tahmasebi, F., Pasbakhsh, P., Mortezaee, K., Madadi, S., Barati, S., & Kashani, I. R.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2019-01-10
- Volume
- 120
- Issue
- 6
- Pages
- 10576-10586
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2909704308
- Cited by
- 52
- References
- 25
- FWCI
- 4.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.